Bicycle Therapeutics plc

BCYC ·Healthcare, Drug Manufacturers - General, United Kingdom
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-16.3M
Depreciation & Amortization $332.0K
Depreciation $300.0K
Amortization —
Stock-Based Compensation $515.0K
Net Cash from Operating Activities $-1.4M
Investing Activities
Capital Expenditures $1.1M
Business Acquisitions —
Net Cash from Investing Activities $-1.1M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $57.9M
Net Change in Cash $58.3M
Free Cash Flow $-2.5M
← Newer Page 2 of 2 Older →